Drugs Made In America Acquisition II Corp. (DMIIU) Notes Payables (2024)
Drugs Made In America Acquisition (DMIIU) posted quarterly Notes Payables of $250100.0 for Q4 2024.
Drugs Made In America Acquisition II Corp. (DMIIU) Notes Payables (2024) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Notes Payables for 1 consecutive years, with $250100.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Notes Payables changed N/A year-over-year to $250100.0; the TTM figure through Dec 2024 stood at $250100.0 (changed N/A YoY), while the FY2024 annual figure was $250100.0, changed N/A from the prior year.
- Notes Payables held at $250100.0 in Q4 2024 per DMIIU's latest filing.
- Across five years, Notes Payables topped out at $250100.0 in Q4 2024 and bottomed at $250100.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 250,100.00 |